by PRI | Dec 6, 2022 | Microbiome Product Developer
Pedro Correa de Sampaio CEO Neobe is building a platform for the engineering of live biotherapeutics aimed at removing stromal barriers to immune infiltration in solid tumours, in order to enable existing immunotherapies in current non responding cancer patients....
by PRI | Jun 20, 2022 | Microbiome Research & Technology (public)
Graeme Brown CBO At the forefront of research into food, the gut microbiome, and human health, the Quadram is a unique partnership between Quadram Institute Bioscience, the Norfolk and Norwich University Hospitals NHS Foundation Trust and the University of East Anglia...
by PRI | Jun 20, 2022 | Microbiome Product Developer
Adam Wilkinson VP Pre-Clinical Development Microbiome biomarker and drug development company with a world-leading microbiome analysis platform....
by PRI | Jun 17, 2022 | Microbiome Pre-Clinical Research (CRO)
Andrew Pridmore Head of Science GLP compliant contract microbiological laboratory services, specializing in antibiotic susceptibility testing and cultivation of highly fastidious bacterial strains....
by PRI | Jun 17, 2022 | Non classé
Debra Barker CMO Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention....
